BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10742708)

  • 1. A comparison of intervention with losartan or captopril in acute myocardial infarction.
    Spinar J; Vitovec J; Spinarova L; Pluhacek L; Fischerova B; Toman J
    Eur J Heart Fail; 2000 Mar; 2(1):91-100. PubMed ID: 10742708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
    Møller JE; Dahlström U; Gøtzsche O; Lahiri A; Skagen K; Andersen GS; Egstrup K;
    Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study.
    Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Giubilato A; Paterna S
    Heart; 1999 Jun; 81(6):606-11. PubMed ID: 10336919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J;
    Lancet; 2002 Sep; 360(9335):752-60. PubMed ID: 12241832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J
    Am J Cardiol; 1999 Feb; 83(4):477-81. PubMed ID: 10073846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction.
    Spinar J; Vitovec J; Pluhacek L; Spinarova L; Fischerova B; Toman J
    Int J Cardiol; 2000 Sep; 75(2-3):197-204. PubMed ID: 11077134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
    Konermann M; Odenthal HJ; Altmann C; Laschewski F; Rawert B; Trappe HJ; Sanner BM
    Wien Med Wochenschr; 2000; 150(12):249-55. PubMed ID: 11008329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction?
    Doggrell SA
    Expert Opin Pharmacother; 2003 Mar; 4(3):407-9. PubMed ID: 12614193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.
    Kyriakidis M; Antonopoulos A; Georgiou E; Santas P; Bakirtzis C; Toutouzas P
    Eur Heart J; 1996 Jun; 17(6):864-73. PubMed ID: 8781825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor blockade.
    Youn TJ; Kim HS; Oh BH
    Basic Res Cardiol; 1999 Aug; 94(4):246-53. PubMed ID: 10505424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
    Konermann M; Altmann C; Laschewski F; Josephs W; Odenthal HJ; Horstmann E; Sanner B
    Clin Cardiol; 1998 Apr; 21(4):277-85. PubMed ID: 9562938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after myocardial infarction in rats: captopril versus losartan.
    Milavetz JJ; Raya TE; Johnson CS; Morkin E; Goldman S
    J Am Coll Cardiol; 1996 Mar; 27(3):714-9. PubMed ID: 8606287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
    Maia LN; Nicolau JC; Vítola JV; Santos M; Brandi JM; Joaquim MR; Baggi JM; Cordeiro JA; de Godoy MF
    Am Heart J; 2003 Jun; 145(6):E21. PubMed ID: 12796769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
    Mill JG; Milanez Mda C; Busatto VC; de Moraes AC; Gomes Mda G
    Arq Bras Cardiol; 1997 Aug; 69(2):101-10. PubMed ID: 9567332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the tissue affinity of ACE inhibitors of relevance for the remodeling of the left ventricular wall following myocardial infarction? Estimations with cine magnetic resonance imaging.
    Konermann M; Sanner BM; Altmann C; Laschewski F; Rawert B; Trappe HJ
    Cardiology; 2000; 94(3):179-87. PubMed ID: 11279324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study.
    Di Pasquale P; Bucca V; Scalzo S; Paterna S
    Cardiovasc Drugs Ther; 1998 May; 12(2):211-6. PubMed ID: 9652880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction.
    Onodera H; Matsunaga T; Tamura Y; Maeda N; Higuma T; Sasaki S; Mori Y; Yoshimachi F; Ishizaka H; Hanada H; Osanai T; Okumura K
    Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of losartan and captopril on ventricular remodeling and function after myocardial infarction in the rat.
    Zhang G; Shen X; Pu S; Yang Y; Pan W; Chen H
    Chin Med Sci J; 1998 Mar; 13(1):32-6. PubMed ID: 11717921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.